Market Overview:

According to IMARC Group's latest research publication, "In Vitro Fertilization Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026-2034", The global in vitro fertilization market size reached USD 28.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 51.3 Billion by 2034, exhibiting a growth rate (CAGR) of 6.90% during 2026-2034.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

How AI is Reshaping the Future of In Vitro Fertilization Market

• AI enhances embryo selection accuracy by analyzing millions of data points from embryo images, increasing success rates from 34% to 65% according to recent Tel Aviv University research, representing a breakthrough in IVF treatment effectiveness.
• Machine learning algorithms optimize ovarian stimulation protocols by considering patient-specific factors including age, weight, hormonal profiles, and genetic predispositions, reducing medication costs and minimizing unnecessary IVF cycles.
• Time-lapse imaging systems powered by AI provide continuous embryo monitoring without disrupting incubation conditions, with leading fertility clinics expanding AI-powered embryo monitoring systems that improve success rates by up to 25%.
• AI adoption in reproductive medicine is growing steadily, rising from 24.8% in 2022 to approximately 29.2% in 2025 among IVF specialists and embryologists globally, with embryo selection as the primary application at 86.3% of AI users.
• Predictive analytics help fertility clinics optimize resource allocation and staffing by forecasting patient schedules and treatment timelines, with AI-powered embryo selection market expected to grow from USD 165.10 Million in 2024 to USD 522.70 Million by 2035.

Download a sample PDF of this report: https://www.imarcgroup.com/in-vitro-fertilization-market/requestsample

Key Trends in the In Vitro Fertilization Market

• Rising Integration of Genetic Screening Technologies: Preimplantation genetic testing (PGT) is becoming standard practice, with the global genetic testing market reaching USD 19.5 Billion in 2024. Advanced genetic screening helps identify genetic disorders before implantation, reducing miscarriage rates by analyzing embryos for conditions like cystic fibrosis, Tay-Sachs disease, and sickle cell anemia, particularly benefiting couples with known genetic predispositions.
• Growing Popularity of Fertility Preservation Techniques: Egg and embryo freezing services are expanding rapidly, driven by delayed parenthood trends. Studies show live birth rates of 41% for embryo cryopreservation and 32% for oocyte preservation, making fertility preservation increasingly attractive for career-focused individuals and cancer patients undergoing treatments that may affect fertility.
• Increasing Emphasis on Personalized Fertility Treatments: Fertility clinics are adopting individualized treatment protocols based on hormonal profiles, genetic predispositions, and medical histories. Personalized IVF protocols optimize success rates by minimizing risks and improving embryo quality, particularly important for patients who have undergone multiple failed IVF cycles.
• Expansion of Medical Tourism in Affordable Markets: Countries like Spain, Czech Republic, Greece, Brazil, Mexico, and Argentina are attracting international patients due to high-quality fertility services at competitive pricing. Europe's medical tourism market reached USD 7.83 Billion in 2023, with India conducting 200,000-250,000 IVF cycles annually, projected to reach 500,000-600,000 cycles by 2026.
• Technological Advancements Improving Success Rates: Innovations including time-lapse imaging, improved cryopreservation techniques through vitrification, and advanced embryo culture methods are enhancing treatment efficiency. Frozen non-donor cycles dominate with 59.7% market share in 2025 due to improved survival rates during freezing and thawing processes.

Growth Factors in the In Vitro Fertilization Market

• Increasing Global Infertility Rates: Rising infertility caused by lifestyle factors, delayed childbearing, obesity, diabetes, and hormonal imbalances is driving IVF demand. In the United States, diabetes prevalence reached 15.8% among adults for August 2021-August 2023, while unhealthy diets account for 54% of total diseases in India according to the Economic Survey.
• Delayed Parenthood Trends: The average age of first-time mothers in the United States has risen to over 27 years, driven by career priorities, education, and financial considerations. By 2044, 75% of Brazilian adults are predicted to be overweight or obese, up from 57% in 2023, contributing to fertility challenges.
• Supportive Government Initiatives and Insurance Coverage: Government-funded IVF programs in European countries and expanding insurance coverage in North America are improving treatment accessibility. Karnataka, India announced free IVF procedures for Below Poverty Line (BPL) cardholders, while GCC countries provide regulatory frameworks and financial assistance programs.
• Growing Social Acceptance and Awareness: As of 2023, 42% of Americans reported either personally using or knowing someone who utilized fertility treatments, up from 33% five years prior. Mainstream media coverage and reduced stigma are encouraging more individuals and couples to seek IVF as a viable solution.
• Expansion of Fertility Clinics and Healthcare Infrastructure: Growing number of specialized fertility centers with advanced facilities and skilled medical personnel is increasing treatment accessibility. GCC health expenditure is estimated to reach USD 135.5 Billion in 2027, supporting the expansion of state-of-the-art fertility clinics.

Leading Companies Operating in the Global In Vitro Fertilization Industry:

• Boston IVF
• CooperSurgical Inc. (The Cooper Companies Inc.)
• Esco Micro Pte. Ltd
• FUJIFILM Holdings Corporation
• Genea Pty Limited
• Hamilton Thorne Ltd.
• SAFE Fertility Center
• Vitrolife AB

In Vitro Fertilization Market Report Segmentation:

Breakup By Product:

• Reagent

           ○         Cryopreservation Media

           ○         Embryo Culture Media

           ○         Ovum Processing Media

           ○         Sperm Processing Media

• Instrument

           ○         Imaging Systems

           ○         Incubators

           ○         Cryosystems

           ○         IVF Cabinet

           ○         Ovum Aspiration Pump

           ○         Sperm Separation Systems

           ○         Micromanipulator Systems

           ○         Others

• Accessories

Instruments dominate the market with 62.6% of the market share in 2025, as they play a crucial role in ensuring precise, efficient, and quality procedures for improved success rates.

Breakup By Procedure Type:

• Fresh Donor
• Frozen Donor
• Fresh Non-donor
• Frozen Non-donor

Frozen non-donor dominates the market with 59.7% of the market share in 2025 due to improved cryopreservation techniques, flexibility in timing, and higher success rates.

Breakup By Cycle Type:

• Conventional IVF
• IVF with ICSI
• IVF with Donor Eggs

IVF with ICSI accounts for 43.0% of the market share in 2025, as it is the most effective method for treating severe male infertility and ensuring successful fertilization.

Breakup By End User:

• Fertility Clinics
• Hospitals
• Others

Fertility clinics hold 63.9% of the market share in 2025 due to specialized expertise, advanced facilities, and personalized patient-centered care.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Europe dominates the market with 37.6% of the market share in 2025, driven by favorable regulatory frameworks, advanced healthcare infrastructure, and widespread insurance coverage for infertility treatments.

Recent News and Developments in In Vitro Fertilization Market

• November 2024: India IVF secured $1.25 million in pre-Series A funding from Tomorrow Capital, marking its first external investment to enhance fertility care access in underserved North Indian regions through a tech-enabled platform offering comprehensive services.
• August 2024: Birla Fertility & IVF (BFI), a Gurgaon-based company, announced plans to open 8-12 new centers across South and West India by FY25, marking its foray into Tamil Nadu, Maharashtra, and Karnataka with the acquisition of 12 BabyScience IVF clinics.
• July 2024: Mira, a US-based hormonal health company, launched an online clinic providing personalized support from fertility professionals to people struggling to conceive, focusing on hormonal imbalances, nutrition, gut health, exercise routines, and mental well-being.
• May 2024: Gameto, a biotechnology company, closed an oversubscribed $33 Million Series B investment round led by Two Sigma Ventures with RA Capital to finish clinical development of Fertilo, their novel investigational in vitro maturation solution for maturing eggs outside the body.
• April 2024: Boston IVF announced that four of its centers were recognized on Newsweek's 2024 list of America's Best Fertility Clinics, highlighting the company's commitment to excellence in reproductive healthcare and comprehensive fertility treatment offerings.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302